Stock News

Biondo Investment Advisors Increased By $609,620 Its Abiomed (ABMD) Holding; Capital International Raised Intel (INTC) Position By $657,800

ABIOMED, Inc. (NASDAQ:ABMD) Logo

Biondo Investment Advisors Llc increased Abiomed Inc (ABMD) stake by 4.9% reported in 2017Q4 SEC filing. Biondo Investment Advisors Llc acquired 3,260 shares as Abiomed Inc (ABMD)’s stock rose 49.46%. The Biondo Investment Advisors Llc holds 69,794 shares with $13.08M value, up from 66,534 last quarter. Abiomed Inc now has $16.87B valuation. The stock decreased 1.11% or $4.25 during the last trading session, reaching $380.11. About 411,306 shares traded. ABIOMED, Inc. (NASDAQ:ABMD) has risen 128.67% since May 21, 2017 and is uptrending. It has outperformed by 117.12% the S&P500.

Capital International Inc increased Intel Corp (INTC) stake by 1021.43% reported in 2017Q4 SEC filing. Capital International Inc acquired 14,300 shares as Intel Corp (INTC)’s stock rose 9.61%. The Capital International Inc holds 15,700 shares with $725,000 value, up from 1,400 last quarter. Intel Corp now has $252.18 billion valuation. The stock increased 1.15% or $0.62 during the last trading session, reaching $54.12. About 17.88M shares traded. Intel Corporation (NASDAQ:INTC) has risen 44.65% since May 21, 2017 and is uptrending. It has outperformed by 33.10% the S&P500.

Biondo Investment Advisors Llc decreased Mastercard Incorporated (NYSE:MA) stake by 6,250 shares to 206,467 valued at $31.25 million in 2017Q4. It also reduced Celgene Corp (NASDAQ:CELG) stake by 5,225 shares and now owns 130,702 shares. Idexx Labs Inc (NASDAQ:IDXX) was reduced too.

Among 15 analysts covering Abiomed (NASDAQ:ABMD), 12 have Buy rating, 0 Sell and 3 Hold. Therefore 80% are positive. Abiomed had 36 analyst reports since August 4, 2015 according to SRatingsIntel. The company was maintained on Friday, February 2 by Stephens. Guggenheim maintained the shares of ABMD in report on Friday, February 2 with “Buy” rating. The stock has “Buy” rating by Stephens on Monday, April 9. The stock of ABIOMED, Inc. (NASDAQ:ABMD) has “Buy” rating given on Thursday, September 21 by Jefferies. Piper Jaffray maintained it with “Buy” rating and $220.0 target in Thursday, January 4 report. The firm has “Buy” rating given on Tuesday, August 18 by Sterne Agee CRT. The stock of ABIOMED, Inc. (NASDAQ:ABMD) earned “Buy” rating by Benchmark on Tuesday, August 4. The rating was maintained by Morgan Stanley with “Equal-Weight” on Tuesday, May 1. Jefferies maintained ABIOMED, Inc. (NASDAQ:ABMD) rating on Thursday, June 29. Jefferies has “Buy” rating and $16500 target. The stock of ABIOMED, Inc. (NASDAQ:ABMD) earned “Overweight” rating by PiperJaffray on Thursday, April 6.

Since February 20, 2018, it had 0 insider purchases, and 5 sales for $31.65 million activity. BOLT WILLIAM J had sold 22,790 shares worth $7.93 million. Shares for $4.70 million were sold by PUHY DOROTHY E on Monday, May 7. 21,890 shares were sold by SUTTER MARTIN P, worth $7.52M on Tuesday, May 8. Greenfield Andrew J sold $5.41M worth of ABIOMED, Inc. (NASDAQ:ABMD) on Tuesday, February 20. Howley Michael G sold 17,500 shares worth $6.09M.

Investors sentiment decreased to 1.18 in Q4 2017. Its down 0.12, from 1.3 in 2017Q3. It turned negative, as 19 investors sold ABMD shares while 110 reduced holdings. 55 funds opened positions while 97 raised stakes. 36.44 million shares or 5.39% less from 38.51 million shares in 2017Q3 were reported. Strs Ohio stated it has 0.1% of its portfolio in ABIOMED, Inc. (NASDAQ:ABMD). Telemus Cap Ltd Liability stated it has 0.03% in ABIOMED, Inc. (NASDAQ:ABMD). Riverhead Capital Management Limited Liability Company, a Delaware-based fund reported 5,079 shares. Brown Brothers Harriman & reported 3,015 shares. Granahan Invest Management Ma accumulated 84,562 shares. Alps Advisors has invested 0.01% in ABIOMED, Inc. (NASDAQ:ABMD). Portolan Capital Llc has 22,440 shares for 0.46% of their portfolio. Mitsubishi Ufj Bk invested in 310,010 shares or 0.1% of the stock. Dorsey Wright Associates holds 1.45% or 42,878 shares in its portfolio. Sei Invests holds 137,552 shares. Macquarie Gru Limited has 0.08% invested in ABIOMED, Inc. (NASDAQ:ABMD). State Treasurer State Of Michigan reported 145,100 shares. Eagle Asset Mngmt has invested 0.27% in ABIOMED, Inc. (NASDAQ:ABMD). Sg Americas Securities Lc stated it has 24,078 shares. Ubs Asset Management Americas Incorporated invested in 0.02% or 106,597 shares.

More important recent ABIOMED, Inc. (NASDAQ:ABMD) news were published by: Benzinga.com which released: “Abiomed Earnings Outlook” on May 02, 2018, also Benzinga.com published article titled: “Benzinga’s Daily Biotech Pulse: Aytu Rallies On Earnings, Evolus Awaits FDA Verdict, BofA Conference Underway”, Nasdaq.com published: “Abiomed Announces Q4 FY 2018 Revenue of $174 Million, Up 40%, and Total Year Revenue of $594 Million, Up 33 …” on May 03, 2018. More interesting news about ABIOMED, Inc. (NASDAQ:ABMD) was released by: Benzinga.com and their article: “Benzinga’s Daily Biotech Pulse: FDA Panel Nod For Akcea, Synergy’s Revenue Miss, FDA Warns E-Liquid Makers Again” with publication date: May 11, 2018.

Capital International Inc decreased Jd.Com Inc A Adr (NASDAQ:JD) stake by 106,400 shares to 39,918 valued at $1.65 million in 2017Q4. It also reduced Idex Corp (NYSE:IEX) stake by 3,486 shares and now owns 4,832 shares. Hexcel Corporation (NYSE:HXL) was reduced too.

Investors sentiment decreased to 1.02 in Q4 2017. Its down 0.01, from 1.03 in 2017Q3. It fall, as 60 investors sold INTC shares while 703 reduced holdings. 177 funds opened positions while 601 raised stakes. 3.06 billion shares or 0.43% more from 3.05 billion shares in 2017Q3 were reported. Smith Moore And holds 0.15% or 12,014 shares in its portfolio. Moreover, Appleton Partners Ma has 0.31% invested in Intel Corporation (NASDAQ:INTC) for 42,650 shares. 16,876 were reported by Trust Of Oklahoma. Grimes & Communication owns 349,101 shares. Narwhal Mgmt holds 160,339 shares. Meiji Yasuda Life Insur Company stated it has 0.75% of its portfolio in Intel Corporation (NASDAQ:INTC). Annex Advisory Svcs Llc owns 35,450 shares. Canal holds 59,044 shares. Cedar Hill Limited Liability has 0.2% invested in Intel Corporation (NASDAQ:INTC) for 24,878 shares. Mufg Americas Holdings stated it has 0.97% in Intel Corporation (NASDAQ:INTC). Autus Asset Mngmt Llc reported 32,793 shares. Qv reported 1.06M shares or 3.89% of all its holdings. Yorktown And Research Company reported 0.64% of its portfolio in Intel Corporation (NASDAQ:INTC). Private Trust Company Na holds 0.54% of its portfolio in Intel Corporation (NASDAQ:INTC) for 55,489 shares. Mechanics Bancorp Department reported 81,583 shares or 0.85% of all its holdings.

Among 55 analysts covering Intel Corporation (NASDAQ:INTC), 36 have Buy rating, 3 Sell and 16 Hold. Therefore 65% are positive. Intel Corporation had 264 analyst reports since August 7, 2015 according to SRatingsIntel. The company was maintained on Monday, August 31 by Canaccord Genuity. On Friday, October 27 the stock rating was maintained by Nomura with “Buy”. On Monday, January 18 the stock rating was maintained by Stifel Nicolaus with “Buy”. KeyBanc Capital Markets maintained it with “Buy” rating and $60.0 target in Thursday, January 25 report. Macquarie Research upgraded the stock to “Outperform” rating in Monday, January 25 report. As per Tuesday, April 17, the company rating was maintained by Susquehanna. The stock has “Hold” rating by Jefferies on Monday, March 13. RBC Capital Markets maintained Intel Corporation (NASDAQ:INTC) rating on Monday, March 12. RBC Capital Markets has “Hold” rating and $46.0 target. The firm has “Buy” rating given on Thursday, January 25 by Stifel Nicolaus. The company was maintained on Tuesday, January 30 by Citigroup.

Intel Corporation (NASDAQ:INTC) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *